Dapagliflozin vs Pembrolizumab

## Dapagliflozin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Dapagliflozin** and **Pembrolizumab**.

## Mechanism of Action

**Dapagliflozin**: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Dapagliflozin — 12.9 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Dapagliflozin — C21H25ClO6; Pembrolizumab — N/A.

**Molecular Weight**: Dapagliflozin — 408.8730 g/mol; Pembrolizumab — N/A.

**Type**: Dapagliflozin — Small molecule; Pembrolizumab — Antibody.